Abstract: A parcel storage device includes a collapsible frame that has a base and a plurality of legs movably attached to the base. A lid is attached to the plurality of legs of the collapsible frame and a drop plate is hingedly integrated into the lid. The drop plate is biased into a closed position and the drop plate is urgeable into an open position to facilitate a parcel to pass through the lid when the parcel is positioned on the drop plate. A shroud is coupled between the base and the lid which defines a storage area to conceal the parcel. A plurality of fingers is each pivotally attached to the lid and extends across the drop plate. Each of the plurality of fingers is urgeable into a downward position to facilitate the parcel to pass into the storage area.

Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

Abstract: A system and method for providing added functionality to a personal transporter by way of adding increased lighting, sound, and cargo carrying options is described. The system can include front, side, and rear lighting and an audio alert system. The system can further include flatbed structures for carrying hazardous or other materials, as well as cargo organizing systems for carrying supplies and equipment.

Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

Abstract: An automated warning system for a platform assembly. The system includes a measuring device mountable on the platform assembly for measuring a parameter representing loading on the assembly, a warning device for generating a warning, and a processor operatively connected to the measuring device and the warning device. The processor is configured to receive information relating to at least one of the design and operation of at least one of the platform assembly and the object, determine a limit for the parameter based on the information, compare the parameter to the limit, and activate the warning device to generate a warning when the parameter compares unfavorably to the limit.

Abstract: The present invention is directed to a nitric gas dispenser for mammals on the run. The dispenser has a housing that contains a valve mechanism. The valve mechanism is interconnected between a nitric gas dispersal component that provides nitric gas at a desired pressure and a gas delivery system that provides the nitric gas at the desired pressure to the mammal. The valve mechanism controls the flow of the nitric gas between the nitric gas dispersal component and the gas delivery system. The dispenser also has a pressure sensor that is positioned along the gas delivery system and determines when the mammal is taking a breadth. If the pressure sensor determines the mammal is taking a breadth, the pressure sensor transmits a breadth signal to a microprocessor. The microprocessor then determines if the mammal is within a prescribed time frame for the mammal to be administered nitric gas.

Abstract: The present invention is directed to a nitric gas dispenser for mammals on the run. The dispenser has a housing that contains a valve mechanism. The valve mechanism is interconnected between a nitric gas dispersal component that provides nitric gas at a desired pressure and a gas delivery system that provides the nitric gas at the desired pressure to the mammal. The valve mechanism controls the flow of the nitric gas between the nitric gas dispersal component and the gas delivery system. The dispenser also has a pressure sensor that is positioned along the gas delivery system and determines when the mammal is taking a breadth. If the pressure sensor determines the mammal is taking a breadth, the pressure sensor transmits a breadth signal to a microprocessor. The microprocessor then determines if the mammal is within a prescribed time frame for the mammal to be administered nitric gas.

Abstract: The administration of aerosolized nitric oxide donors or type V phosphodiesterase inhibitor in controlled doses to horses during high intensity exercise is described. Aerosolized nitric oxide donors (in conjunction with intravenous type V phosphodiesterase inhibitor) and type V phosphodiesterase inhibitor are beneficial to prevent exercise induced pulmonary hemorrhage by reducing transmural pulmonary artery pressure with a concomitant decrease in pulmonary capillary stress failure. The administration of aerosolized nitric oxide donors and type V phosphodiesterase inhibitors is viewed as a novel therapeutic modality in the alleviation of capillary stress failure and EIPH in performance horses.